top of page
Charles River_Banner_1200 x 630_Revolutionise Medicine.png

About Charles River

Charles River is a visionary leader in the development and delivery of advanced drug therapies. We provide essential products and services to pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe, to help accelerate their research and drug development efforts.

 

At Charles River, we view every day as an opportunity to improve global health and people's lives. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

 

Your moment to use your talents to make a real difference is here and now.

 

Below is a quick snapshot of our company:

 

  • Founded: 1947

  • Headquarters: Wilmington, MA

  • Employees: 20,000+ worldwide

  • Revenue: $3.5 billion in FY2021

  • Ownership: Publicly traded (CRL)

  • Customers: Leading pharmaceutical, biotechnology, agrochemical, government, and academic organisations around the world

  • Service Areas: Basic research, discovery, safety and efficacy, clinical support, and manufacturing

CR-about-us-infographic.png

Corporate Citizenship Report 

Our 2023 Corporate Citizenship Report exemplifies our commitment to operating our business responsibly and demonstrates our passion in improving the quality of people's lives. 

The report details our progress across four strategic Environmental, Social, and Governance (ESG) Pillars: 

  • Accelerate Life-Saving Therapies

  • Lead with Integrity

  • Inspire our People

  • Protect our Planet

Find out more by following this link: Our Commitment to Corporate Citizenship

  • LinkedIn

Jim Foster, Chairman and CEO

"As I look to the future, our strategy remains clear: deliver life-saving treatments to patients faster, with a focus on inclusive and sustainable growth, driven by technology innovations and responsible animal use."

bottom of page